JP2019526270A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526270A5 JP2019526270A5 JP2019513999A JP2019513999A JP2019526270A5 JP 2019526270 A5 JP2019526270 A5 JP 2019526270A5 JP 2019513999 A JP2019513999 A JP 2019513999A JP 2019513999 A JP2019513999 A JP 2019513999A JP 2019526270 A5 JP2019526270 A5 JP 2019526270A5
- Authority
- JP
- Japan
- Prior art keywords
- bcr
- nucleic acid
- acid encoding
- primary
- therapeutic cassette
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108091008875 B cell receptors Proteins 0.000 claims 6
- 230000001225 therapeutic effect Effects 0.000 claims 5
- 210000003719 b-lymphocyte Anatomy 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 239000003623 enhancer Substances 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 229940123611 Genome editing Drugs 0.000 claims 1
- 238000010362 genome editing Methods 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022162584A JP2022189863A (ja) | 2016-09-12 | 2022-10-07 | ゲノム編集初代ｂ細胞ならびに作製方法および使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662393512P | 2016-09-12 | 2016-09-12 | |
| US62/393,512 | 2016-09-12 | ||
| PCT/US2017/051182 WO2018049401A1 (en) | 2016-09-12 | 2017-09-12 | Genome edited primary b cell and methods of making and using |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022162584A Division JP2022189863A (ja) | 2016-09-12 | 2022-10-07 | ゲノム編集初代ｂ細胞ならびに作製方法および使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019526270A JP2019526270A (ja) | 2019-09-19 |
| JP2019526270A5 true JP2019526270A5 (OSRAM) | 2020-10-22 |
Family
ID=61562180
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019513999A Withdrawn JP2019526270A (ja) | 2016-09-12 | 2017-09-12 | ゲノム編集初代ｂ細胞ならびに作製方法および使用方法 |
| JP2022162584A Pending JP2022189863A (ja) | 2016-09-12 | 2022-10-07 | ゲノム編集初代ｂ細胞ならびに作製方法および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022162584A Pending JP2022189863A (ja) | 2016-09-12 | 2022-10-07 | ゲノム編集初代ｂ細胞ならびに作製方法および使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220168342A1 (OSRAM) |
| EP (1) | EP3509606A4 (OSRAM) |
| JP (2) | JP2019526270A (OSRAM) |
| CN (1) | CN109843303A (OSRAM) |
| AU (1) | AU2017322733B2 (OSRAM) |
| CA (1) | CA3036820A1 (OSRAM) |
| WO (1) | WO2018049401A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11939594B2 (en) | 2017-03-16 | 2024-03-26 | Seattle Children's Hospital | Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins |
| WO2021108650A1 (en) * | 2019-11-27 | 2021-06-03 | Board Of Regents, The University Of Texas System | Large-scale combined car transduction and crispr gene editing of b cells |
| WO2023283585A2 (en) * | 2021-07-06 | 2023-01-12 | Vor Biopharma Inc. | Inhibitor oligonucleotides and methods of use thereof |
| WO2023010125A1 (en) * | 2021-07-29 | 2023-02-02 | Regents Of The University Of Minnesota | Multiplex base editing of primary human natural killer cells |
| EP4555091A2 (en) * | 2022-07-13 | 2025-05-21 | Vor Biopharma Inc. | Compositions and methods for artificial protospacer adjacent motif (pam) generation |
| WO2024196669A2 (en) * | 2023-03-17 | 2024-09-26 | Walking Fish Therapeutics, Inc. | Methods for in vivo editing of b cells |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016062898A1 (en) * | 2014-10-24 | 2016-04-28 | Bcrt Holding Bv | T cell-based immunotherapeutics |
| PL3234107T3 (pl) * | 2014-12-19 | 2023-01-16 | Immusoft Corporation | Limfocyty b do dostarczania in vivo środków terapeutycznych |
| AU2016243052C1 (en) * | 2015-04-03 | 2022-11-24 | Dana-Farber Cancer Institute, Inc. | Composition and methods of genome editing of B-cells |
-
2017
- 2017-09-12 EP EP17849776.4A patent/EP3509606A4/en active Pending
- 2017-09-12 CA CA3036820A patent/CA3036820A1/en active Pending
- 2017-09-12 AU AU2017322733A patent/AU2017322733B2/en active Active
- 2017-09-12 JP JP2019513999A patent/JP2019526270A/ja not_active Withdrawn
- 2017-09-12 US US16/332,555 patent/US20220168342A1/en active Pending
- 2017-09-12 CN CN201780059655.8A patent/CN109843303A/zh active Pending
- 2017-09-12 WO PCT/US2017/051182 patent/WO2018049401A1/en not_active Ceased
-
2022
- 2022-10-07 JP JP2022162584A patent/JP2022189863A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526270A5 (OSRAM) | ||
| WO2015112626A8 (en) | Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules | |
| PH12019501241A1 (en) | Novel t cell receptors and immune therapy using the same | |
| CY1123028T1 (el) | Σταθερα και διαλυτα αντισωματα που αναστελλουν τον vegf | |
| CA3045233A1 (en) | Novel t cell receptors and immune therapy using the same | |
| JP2010227108A5 (OSRAM) | ||
| PH12018502544A1 (en) | Antibody for binding to interleukin 4 receptor | |
| WO2018104909A3 (en) | Dna methylation profiling for t-cell immunotherapy | |
| MY189819A (en) | Genetically modified cells and uses thereof | |
| BR112017014031A2 (pt) | n-oligossacaril-transferase recombinante, mutante de n-oligossacaril-transferase recombinante, ácido nucleico, célula hospedeira, e, método para produção de um bioconjugado. | |
| EA202091166A1 (ru) | ПОЛИПЕПТИДЫ, СОДЕРЖАЩИЕ Fc С ИЗМЕНЕННЫМ ГЛИКОЗИЛИРОВАНИЕМ И СНИЖЕННОЙ ЭФФЕКТОРНОЙ ФУНКЦИЕЙ | |
| RU2018132044A (ru) | Антитела против тау | |
| CR20190431A (es) | Formatos mejorados de receptor de unión a antígeno | |
| JP2011152135A5 (OSRAM) | ||
| WO2018102787A9 (en) | Methods for determining car-t cells dosing | |
| WO2014009438A3 (en) | Mycobacterial antigen vaccine | |
| EA201370076A1 (ru) | Иммуноглобулины-переносчики и их применение | |
| JP2016510594A5 (OSRAM) | ||
| JP2013539454A5 (OSRAM) | ||
| UA110473C2 (uk) | Спосіб лікування раку за допомогою пухлиноасоційованого антигену, отриманого із цикліну d1 | |
| WO2015035250A3 (en) | Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with improved clinical outcome | |
| FI3792628T3 (fi) | Menetelmiä neoantigeenien hyödyllisyyden ennustamiseen immunoterapiassa | |
| WO2016100328A8 (en) | Novel tilapia virus and uses thereof | |
| JP2018023397A5 (OSRAM) | ||
| HRP20230605T1 (hr) | Protutijela protiv interferona beta i njihova upotreba |